Summary
Bridge Biotherapeutics Inc
Founded in 2015
Strengths
- Revenue generated per employee is greater than industry average
- Demonstrating revenue growth that is faster than the industry average
- The number of employees is growing faster than the industry average
- Since Bridge Biotherapeutics Inc was founded, the company has grown faster than the industry average
Weaknesses
- Bridge Biotherapeutics Inc has a very small market share in their industry
- Variance of revenue growth is more than the industry average
Annual Revenue
Bridge Biotherapeutics Inc's annual revenue
$6692000
Based on Kona Equity data
-
Revenue per employee
$304181
-
Variance of revenue growth
0.63
-
Annual revenue growth since founding
$743555
-
Revenue growth rate from first known quarter to current
561.1%
Employee Count
22 employees
-
Employee growth rate from first known quarter to current
540.0%
Executives
Sang-Uk Kang
Senior VP, Research & Development
s**@bridgebiorx.comDeborah Kim
Med- Chem and CMC Director
d**@bridgebiorx.comMikyoung Chang
Director, Scientific Affairs and Scientific Liaison
m**@bridgebiorx.comJehrod Brenneman
Senior Director, Medicinal Chemistry
j**@bridgebiorx.comSungchan Jeong
Senior Director
s**@bridgebiorx.comNaeun Jeon
Clinical Trial Leader
n**@bridgebiorx.comLeila Revollo
Scientist I
l**@bridgebiorx.comPavel Printsev
Director, Business Development
p**@bridgebiorx.comYounhee Jung
Manager, Prc Research
y**@bridgebiorx.comChris Kim
Executive Vice President
c**@bridgebiorx.comPeter Park
Director, Finance & Operations
p**@bridgebiorx.comKim Soomin
Manager
k**@bridgebiorx.comAngela Yum
Clinical Development Strategy Head
a**@bridgebiorx.comJeong-Min Chun
Head Senior Director, Clinical Operations
j**@bridgebiorx.comKim Chulwon
Director, Research
k**@bridgebiorx.comJoengbin Ahn
Director, Communications
j**@bridgebiorx.comJin Lim
Senior Director, Strategy
j**@bridgebiorx.comJimmy Jin
Head of Discovery Biology
j**@bridgebiorx.comZieun Chang
Manager, Prc Research
z**@bridgebiorx.comLee Gwanghee
Head Vice President, Translational Research
l**@bridgebiorx.comKyungah Kim
Manager
k**@bridgebiorx.comG Score - 4
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G2 Income per employee more than industry average.
- G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
- G4 Employee growth rate from the first known quarter to current is higher than the industry average.
- G6 Annual revenue growth since founding is higher than the industry average.
Location
Unlock unlimited leads
Similar Companies
Key Information
- Name: Bridge Biotherapeutics Inc
- Category: Biotechnology
- Industry: Corporate office
- SIC: 2834; 283
- NAICS: 32541; 3254
See similar companies
-
By City Houston Small Corporate office in Houston Mid-size Corporate office in Houston Biotechnology in Houston Small Biotechnology in Houston Mid-size Biotechnology in Houston
-
By State TX Small companies in TX Biotechnology in TX Small Biotechnology in TX Mid-size Biotechnology in TX Small Corporate office in TX Mid-size Corporate office in TX
-
By Category Biotechnology Small Biotechnology Mid-size Biotechnology
-
By Industry Corporate office Small Corporate office Mid-size Corporate office Biotechnology and Corporate office
-
Firmographic data G Score of 4 Founded in 2015 SIC: 2834 SIC: 283 NAICS: 32541 NAICS: 3254 #Pharmaceuticals #Healthcare #Biotechnology #Drug Manufacturing & Research
Frequently Asked Questions
Bridge Biotherapeutics Inc's headquarters are located at 2450 Holcombe Blvd. Houston, TX 77021.
Bridge Biotherapeutics Inc's official website is bridgebiorx.com
Bridge Biotherapeutics Inc's annual revenue is $6.7 M.
Bridge Biotherapeutics Inc's SIC: 2834; 283
Bridge Biotherapeutics Inc's NAICS: 32541; 3254.
Bridge Biotherapeutics Inc has 22 employees
Bridge Biotherapeutics Inc is in the industry of Biotechnology.